
Ozempic (semaglutide) is a GLP-1 receptor agonist licensed in the UK for managing type 2 diabetes mellitus. Whilst effective at improving blood glucose control and promoting weight loss, some patients report digestive side effects, including acid reflux and heartburn. These symptoms are primarily linked to Ozempic's mechanism of slowing gastric emptying, which can increase gastric pressure and allow stomach acid to reflux into the oesophagus. Understanding the relationship between Ozempic and reflux symptoms, alongside practical management strategies, helps patients optimise treatment whilst maintaining digestive comfort and diabetes control.
Quick Answer: Ozempic can cause acid reflux or heartburn in some patients, primarily by slowing gastric emptying, which increases gastric pressure and allows stomach acid to reflux into the oesophagus.
Ozempic (semaglutide) is a prescription medication licensed in the UK for the treatment of type 2 diabetes mellitus. It belongs to a class of drugs known as glucagon-like peptide-1 (GLP-1) receptor agonists, which work by mimicking the action of a naturally occurring hormone called GLP-1.
The primary mechanism of action involves several complementary effects on glucose metabolism. Ozempic stimulates insulin secretion from the pancreas in a glucose-dependent manner, meaning it only triggers insulin release when blood sugar levels are elevated. This reduces the risk of hypoglycaemia compared to some other diabetes medications. Additionally, it suppresses the release of glucagon, a hormone that raises blood glucose levels, and slows gastric emptying—the rate at which food leaves the stomach and enters the small intestine.
This delayed gastric emptying is particularly relevant when considering digestive side effects. By slowing the movement of food through the digestive system, Ozempic helps patients feel fuller for longer, which contributes to weight loss—a beneficial effect for many people with type 2 diabetes. The medication is administered once weekly via subcutaneous injection, typically in the abdomen, thigh, or upper arm.
Ozempic is initiated at a lower dose (0.25mg weekly) for four weeks, then increased to 0.5mg weekly, with potential further titration to improve glycaemic control. This gradual dose escalation helps improve gastrointestinal tolerability.
Ozempic has been shown in clinical trials to effectively lower HbA1c levels (a measure of long-term blood glucose control) and promote weight reduction. While weight loss can be beneficial, it's important to note that in the UK, Ozempic is licensed specifically for type 2 diabetes management, not as a weight loss treatment. The Medicines and Healthcare products Regulatory Agency (MHRA) has approved its use, and NICE guidelines (NG28) recognise GLP-1 receptor agonists as valuable treatment options for appropriate patients with type 2 diabetes, particularly those who would benefit from weight loss or where other medications have proven insufficient.
Mounjaro® is the most innovative GLP-1 medication proven to dramatically curb appetite, hunger, and cravings to help professional men achieve substantial weight loss.
Start Here
Wegovy® is a weekly injectable GLP-1 medication with proven effectiveness in reducing appetite, hunger, and cravings to help busy professionals lose significant weight.
Start HereGastrointestinal side effects are among the most commonly reported adverse reactions associated with Ozempic, and acid reflux or heartburn can occur in some patients. According to the Summary of Product Characteristics (SmPC), while nausea is common (affecting ≥1/100 to <1/10 patients), dyspepsia (indigestion) and gastro-oesophageal reflux disease are listed as less common side effects.
The relationship between Ozempic and acid reflux is primarily linked to the medication's effect on gastric motility. By significantly slowing gastric emptying, food remains in the stomach for extended periods. This prolonged retention can increase gastric pressure and potentially allow stomach acid to reflux back into the oesophagus, causing the burning sensation characteristic of heartburn or gastro-oesophageal reflux disease (GORD).
Clinical trial data indicates that nausea is the most prevalent gastrointestinal complaint, affecting approximately 15-20% of patients, particularly during dose escalation. Vomiting occurs less frequently. Dyspepsia (indigestion) and abdominal discomfort are also documented in the SmPC. These overlapping symptoms suggest that reflux-type complaints do affect a proportion of users.
It is important to note that not all patients will experience acid reflux whilst taking Ozempic. Individual susceptibility varies considerably, and pre-existing conditions such as hiatus hernia, obesity, or previous GORD may increase the likelihood of developing reflux symptoms. The severity of symptoms also tends to be dose-dependent and may improve as the body adjusts to the medication over several weeks.
The SmPC advises caution when using GLP-1 receptor agonists in patients with severe gastrointestinal disease, including severe gastroparesis, as these medications may worsen digestive symptoms in such conditions.
Patients should be reassured that experiencing some digestive discomfort does not necessarily mean they must discontinue treatment, as there are effective management strategies available.

If you develop acid reflux or heartburn whilst taking Ozempic, several practical lifestyle modifications and medical interventions can help manage these symptoms effectively without necessarily requiring discontinuation of your diabetes medication.
Dietary adjustments form the cornerstone of reflux management:
Eat smaller, more frequent meals rather than large portions, which can exacerbate gastric pressure
Avoid trigger foods such as spicy dishes, citrus fruits, tomatoes, chocolate, caffeine, and fatty or fried foods
Reduce alcohol consumption, particularly spirits and wine, which can relax the lower oesophageal sphincter
Stay upright after eating for at least two to three hours before lying down
Elevate the head of your bed by 15–20 cm using blocks or a wedge pillow to prevent nocturnal reflux
Stop smoking if applicable, as smoking can worsen reflux symptoms
Avoid tight clothing around the waist that increases abdominal pressure
From a pharmacological perspective, over-the-counter antacids containing magnesium or calcium carbonate (such as Gaviscon or Rennie) can provide rapid, short-term relief by neutralising stomach acid. Your local pharmacist can advise on appropriate options. For more persistent symptoms, your GP may recommend:
Proton pump inhibitors (PPIs) such as omeprazole or lansoprazole, which reduce acid production
H2-receptor antagonists such as famotidine, which also decrease acid secretion
These medications are generally safe to use alongside Ozempic, though you should always inform your healthcare provider about all medications you are taking. Weight loss achieved through Ozempic treatment may paradoxically improve reflux symptoms over time, as excess abdominal weight is a significant risk factor for GORD.
Maintaining good hydration throughout the day, whilst avoiding large fluid volumes with meals, can also help manage symptoms without overwhelming the stomach. These approaches align with NICE Clinical Guideline 184 for managing gastro-oesophageal reflux disease and dyspepsia in adults.
Whilst mild digestive discomfort is relatively common when starting Ozempic, certain symptoms warrant prompt medical attention. Understanding when to contact your GP or seek urgent care is essential for patient safety.
Contact your GP if you experience:
Persistent or worsening reflux symptoms that do not improve with lifestyle modifications or over-the-counter remedies after two weeks
Difficulty swallowing (dysphagia) or a sensation of food sticking in the chest
Unintentional weight loss beyond what is expected from diabetes management
Persistent nausea or vomiting that prevents adequate food or fluid intake
Signs of dehydration including dark urine, dizziness, or reduced urination
Right upper abdominal pain, fever or yellowing of the skin/eyes, which could indicate gallbladder disease—a known risk with GLP-1 receptor agonists
According to NICE guideline NG12, certain symptoms require urgent specialist referral (within two weeks), including:
Dysphagia (difficulty swallowing) at any age
If you're aged 55 and over with weight loss and upper abdominal pain, reflux, or dyspepsia
Seek immediate medical attention (A&E or call 999) if you develop:
Severe, persistent abdominal pain, particularly in the upper abdomen radiating to the back, which could indicate pancreatitis—a rare but serious side effect of GLP-1 receptor agonists
Vomiting blood or passing black, tarry stools, suggesting gastrointestinal bleeding
Severe chest pain that could represent cardiac issues rather than simple reflux
Your GP may need to review your medication regimen if side effects are significantly impacting your quality of life. This might involve temporarily reducing the Ozempic dose, adding medications to manage reflux, or considering alternative diabetes treatments. NICE guidance emphasises individualised treatment approaches, balancing glycaemic control with tolerability.
It is also important to attend regular diabetes reviews where your HbA1c, weight, and overall treatment response can be monitored. During these appointments, discuss any digestive symptoms openly, even if they seem minor, as early intervention can prevent more troublesome complications.
Never discontinue Ozempic abruptly without medical guidance, as this could compromise your diabetes control. Your healthcare team can work with you to find the most appropriate management strategy that addresses both your blood glucose levels and digestive comfort.
If you suspect you're experiencing side effects from Ozempic, you can report these through the MHRA Yellow Card Scheme, which helps monitor medication safety in the UK.
Dyspepsia and gastro-oesophageal reflux disease are listed as less common side effects of Ozempic, whilst nausea affects approximately 15-20% of patients. Individual susceptibility varies, and pre-existing conditions such as hiatus hernia or obesity may increase the likelihood of developing reflux symptoms.
Yes, over-the-counter antacids and prescription medications such as proton pump inhibitors (PPIs) or H2-receptor antagonists are generally safe to use alongside Ozempic. Always inform your GP or pharmacist about all medications you are taking to ensure appropriate management.
Contact your GP if reflux symptoms persist or worsen after two weeks despite lifestyle modifications, if you experience difficulty swallowing, persistent vomiting, signs of dehydration, or upper abdominal pain. Seek immediate medical attention for severe abdominal pain, vomiting blood, or black stools.
All medical content on this blog is created based on reputable, evidence-based sources and reviewed regularly for accuracy and relevance. While we strive to keep content up to date with the latest research and clinical guidelines, it is intended for general informational purposes only.
DisclaimerThis content is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional with any medical questions or concerns. Use of the information is at your own risk, and we are not responsible for any consequences resulting from its use.